A detailed history of William Blair Investment Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, William Blair Investment Management, LLC holds 57,244 shares of AZN stock, worth $3.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,244
Previous 57,252 0.01%
Holding current value
$3.9 Million
Previous $4.47 Million 0.11%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$76.67 - $87.62 $613 - $700
-8 Reduced 0.01%
57,244 $4.46 Million
Q2 2024

Aug 08, 2024

SELL
$66.81 - $80.83 $1.16 Million - $1.41 Million
-17,390 Reduced 23.3%
57,252 $4.47 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $115,224 - $131,348
1,888 Added 2.6%
74,642 $5.06 Million
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $160,295 - $179,435
-2,590 Reduced 3.44%
72,754 $4.9 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $309,723 - $342,439
4,776 Added 6.77%
75,344 $5.1 Million
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $689,871 - $748,093
9,868 Added 16.26%
70,568 $5.05 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $18,566 - $21,050
-294 Reduced 0.48%
60,700 $4.21 Million
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $410,315 - $533,160
7,569 Added 14.17%
60,994 $4.14 Million
Q3 2022

Nov 09, 2022

SELL
$53.02 - $135.75 $54,186 - $138,736
-1,022 Reduced 1.88%
53,425 $2.93 Million
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $156,031 - $187,311
-2,633 Reduced 4.61%
54,447 $3.6 Million
Q1 2022

May 11, 2022

BUY
$55.72 - $67.12 $3.18 Million - $3.83 Million
57,080 New
57,080 $3.79 Million
Q1 2020

May 08, 2020

SELL
$37.79 - $51.33 $3.34 Million - $4.53 Million
-88,333 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$42.46 - $50.46 $7,897 - $9,385
186 Added 0.21%
88,333 $4.4 Million
Q3 2019

Nov 12, 2019

SELL
$40.12 - $45.47 $736,402 - $834,601
-18,355 Reduced 17.23%
88,147 $3.93 Million
Q2 2019

Aug 09, 2019

SELL
$37.28 - $41.68 $1.79 Million - $2 Million
-47,883 Reduced 31.02%
106,502 $4.4 Million
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $1.45 Million - $1.76 Million
-40,838 Reduced 20.92%
154,385 $6.24 Million
Q4 2018

Feb 13, 2019

BUY
$36.86 - $41.49 $959,613 - $1.08 Million
26,034 Added 15.39%
195,223 $7.42 Million
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $1.69 Million - $1.93 Million
48,662 Added 40.37%
169,189 $6.7 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $1.87 Million - $2.01 Million
-54,222 Reduced 31.03%
120,527 $4.23 Million
Q1 2018

May 14, 2018

BUY
$32.97 - $36.63 $923,654 - $1.03 Million
28,015 Added 19.09%
174,749 $6.11 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $6,642 - $7,199
207 Added 0.14%
146,734 $5.09 Million
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $4.24 Million - $4.98 Million
146,527
146,527 $4.96 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.